These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2730708)

  • 1. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.
    Vlasova II
    Platelets; 2000 Nov; 11(7):406-14. PubMed ID: 11132108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.
    Takahashi Y; Chiba H; Matsuno K; Akita H; Hui SP; Nagasaka H; Nakamura H; Kobayashi K; Tandon NN; Jamieson GA
    Biochem Biophys Res Commun; 1996 May; 222(2):453-9. PubMed ID: 8670226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonate transfer between platelets and lipoproteins.
    Surya II; Gorter G; Akkerman JW
    Thromb Haemost; 1992 Dec; 68(6):719-26. PubMed ID: 1287888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2.
    Weidtmann A; Scheithe R; Hrboticky N; Pietsch A; Lorenz R; Siess W
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1131-8. PubMed ID: 7627706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in platelets and vascular endothelial cells induced by glycated lipoproteins.
    Takeda H; Yano T; Kishikawa H; Miyata T; Shinohara M; Yamaguchi E; Kobori S; Fan JL; Tokunaga O; Shichiri M
    Intern Med; 1992 Jun; 31(6):746-51. PubMed ID: 1392175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
    Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I; Roth A; Moeslinger T; Cooper J; Schmid W; Zehetgruber M; Koller E
    Thromb Res; 2000 Mar; 97(6):441-9. PubMed ID: 10704653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins.
    Andrews HE; Aitken JW; Hassall DG; Skinner VO; Bruckdorfer KR
    Biochem J; 1987 Mar; 242(2):559-64. PubMed ID: 3109394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interactions of modified lipoproteins with human erythrocyte membranes.
    Jóźwiak Z; Pałecz D; Bartosz G
    Biochem Mol Biol Int; 1994 Feb; 32(2):259-67. PubMed ID: 8019431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A; Svensson B; Wiebe D; Hoak JC
    Circ Res; 1978 Oct; 43(4):527-34. PubMed ID: 210972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.
    Valiyaveettil M; Kar N; Ashraf MZ; Byzova TV; Febbraio M; Podrez EA
    Blood; 2008 Feb; 111(4):1962-71. PubMed ID: 17993610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood.
    Tornvall P; Chirkova L; Toverud KD; Horowitz JD; Chirkov Y
    Thromb Res; 1999 Aug; 95(4):177-83. PubMed ID: 10498387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect.
    Mahfouz MM; Kummerow FA
    Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
    Mehta JL; Chen LY
    J Lab Clin Med; 1996 Mar; 127(3):287-95. PubMed ID: 9273362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis.
    Jambou D; Dejour N; Bayer P; Poirée JC; Frédenrich A; Issa-Sayegh M; Adjovi-Desouza M; Lapalus P; Harter M
    Biochim Biophys Acta; 1993 May; 1168(1):115-21. PubMed ID: 8504137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.